Charles Miller, MD

home

authors

charles-miller-md

 for coverage from last year's AAGL conference from Las Vegas, Nevada.

OBGYN.net proudly supports education for women on minimally invasive procedures

In the U.S. there are over 600,000 hysterectomies performed each year, about 1,643 a day. In fact, by the age of 60, 1 in 3 women will have had a hysterectomy. You may be feeling anxious, but remember that there are 599,999 other women this year who will feel like you. In addition, you can take comfort in knowing that recent medical advances have made this common procedure much less invasive. Follow these links to OBGYN.net resources tthat help you get the most minimally invasive treatment option possible:

Hysterectomy Resource Center - "Dawn" takes charge of her hysterectomy!

Fibroid Resource Center - Ask questions and get personal answers from the world's top physicians treating fibroid tumors!

Articles

Coverage of 36th AAGL Congress November 2007, Washington, DC

Patients Public Relation Initiative

Good afternoon, I am Dr Charles Miller from Chicago. I would  like to talk with you about current options for the treatment of symptomatic  uterine fibroids.
 
 When I talk with patients, I basically talk about three different options:  medical treatment, radiologic treatment, as well as surgical treatment. From a  standpoint of medical treatment, I do not recommend birth control pills. Birth  control pills can actually stimulate the growth of uterine fibroids. The only  treatment available at the present time that really offers the ability to shrink  fibroids and to prevent their growth is the use of GnRH agonists. The most  popular one is Lupron in the United States. Now Lupron causes a marked decrease  in both estrogen and progesterone production. In so doing, the fibroids will  shrink upward of 30% to 40%. A problem can come if you take the patient off the  Lupron, the fibroids will return, so this treatment is usually done prior to  surgery. In a patient who has a number of fibroids and is not a candidate for  surgery at the present time, she may, in fact, use Lupron for the long-term. If  that is going to be the case, you must use what we call add-back therapy; that  is, estrogen and progesterone to prevent bone loss that is caused by the GnRH  agonist.
 
 A second type of treatment is radiologic treatment. That is the use of uterine  artery embolization. Basically, the vessels to the uterus, the uterine arteries,  are blocked through a catheter that is placed through the groin in radiology.  Ultimately, those vessels are blocked, causing decreased flow to the uterus and  to the fibroids. Again, the fibroid will shrink approximately 30% to 40%. The  advantage of the procedure is that it is non-surgical. Patients are generally on  their feet within about 72 hours. There is approximately a 90% success rate with  control of pain and an 85% success rate with control of bulk symptoms. I think I  said that wrong, about a 90% success rate in control of bleeding and an 85%  control of pain associated with the fibroids. But all is not perfect with  uterine artery embolization. For example, women over the age of 40, women in  their mid-40s, are at a high risk of menopause after uterine artery  embolization. Ultimately, 15% to 20%. Secondly, there is a concern we have of  post-embolization syndrome. That is when in approximately 30 days, patients can  have problems with fevers, general lethargy and tiredness and feeling out of  sorts. Those are concerns we have with uterine artery embolization. Finally,  there is about a 30% recurrence with UAE.
 
 So after speaking about medical and radiologic options, our last option is  surgical. Surgical can be just dealing with the fibroids themselves. Myomectomy,  either through use of the laparoscope, an abdominal incision or a hysteroscope.  Depending on the placement of the fibroid, a vaginal approach use of a telescope  that goes in the uterus called a hysteroscope is the best option. But that means  the fibroid has to be actually in the cavity of the uterus. If the fibroid is in  the muscle of the uterus or outside the uterus near or next to the abdominal  cavity, then a laparoscopic myomectomy or an open myomectomy through a  laparotomy incision, a big incision has to be performed. Now when it comes to  that type of approach, I generally definitely favor a laparoscopic approach.  Laparoscopic approach has been shown to cause fewer adhesion formations and  there is definitely quicker recovery. Finally, we get into hysterectomy. Still  the number one reason for hysterectomy in the United States is uterine fibroids:  40% of hysterectomies in the United States are due to uterine fibroids. We can  use two techniques: either a total laparoscopic hysterectomy or a total  hysterectomy, where all of the uterus and the cervix plus the fibroids are  removed or a laparoscopic supracervical hysterectomy where one only removes the  upper portion of the uterus plus the fibroids; the cervix remains. I mention the  word laparoscopic and I probably should not say that right off the bat because  there are three techniques to performing hysterectomy: open technique through  the laparotomy incision, we call it an abdominal hysterectomy; through the  vagina, a vaginal hysterectomy; or laparoscopic. Again, if one is doing a total  laparoscopic hysterectomy, removing the cervix, as well, a vaginal approach is  fine and certainly an excellent approach if that can be the technique the  surgeon uses. Unfortunately, often times, the uterus is too large. Ultimately,  it comes down to laparotomy or laparoscopy. Again, I favor a laparoscopic  technique because of quicker recovery, less morbidity, fewer problems, fewer  complications with the procedure.
 
 At the end of the day, however, you have to discuss your case with your  physician and develop a plan. The important thing for you to know is your  physician must give you options. If there is no other option than hysterectomy,  you need to get a second opinion. Thanks for your time.

From the 34th Annual Meeting - Chicago, Illinois - November 2005

Current Options for the Treatment of Symptomatic Uterine Fibroids

The file you requested will begin playing automatically.  If it does not, press the 'play' button.   If you experience playback problems, make certain you have the latest version of Windows Media Player, available 

.   If you have the latest Windows Media Player and still experience problems, 

  with a description of the problem and any error messages you may have received.

Author | Charles Miller, MD

Articles

Patients Public Relation Initiative

Current Options for the Treatment of Symptomatic Uterine Fibroids

Current Options for the Treatment of Symptomatic Uterine Fibroids Video